Feedback / Questions
HXN-1002 - Sanofi
HXN-1003 - Sanofi
https://www.prnewswire.com/news-releases/earendil-labs-announces-worldwide-exclusive-license-agreement-with-sanofi-for-next-generation-bispecific-antibodies-for-autoimmune-and-inflammatory-bowel-diseases-302431020.html
 
Apr 17, 2025
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious